UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:FUS-CREB3L2 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: FUS-CREB3L2 | FusionPDB ID: 31795 | FusionGDB2.0 ID: 31795 | Hgene | Tgene | Gene symbol | FUS | CREB3L2 | Gene ID | 2521 | 64764 |
Gene name | FUS RNA binding protein | cAMP responsive element binding protein 3 like 2 | |
Synonyms | ALS6|ETM4|FUS1|HNRNPP2|POMP75|TLS | BBF2H7 | |
Cytomap | 16p11.2 | 7q33 | |
Type of gene | protein-coding | protein-coding | |
Description | RNA-binding protein FUS75 kDa DNA-pairing proteinfus-like proteinfused in sarcomafusion gene in myxoid liposarcomaheterogeneous nuclear ribonucleoprotein P2oncogene FUSoncogene TLStranslocated in liposarcoma protein | cyclic AMP-responsive element-binding protein 3-like protein 2B-ZIB transcription factorBBF2 human homolog on chromosome 7FUS/BBF2H7 proteinTCAG_1951439basic transcription factor 2cAMP-responsive element-binding protein 3-like protein 2 | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | P35637 | Q70SY1 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000254108, ENST00000380244, ENST00000568685, ENST00000474990, | ENST00000330387, ENST00000452463, ENST00000456390, ENST00000458726, ENST00000468127, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 37 X 37 X 16=21904 | 5 X 10 X 5=250 |
# samples | 44 | 9 | |
** MAII score | log2(44/21904*10)=-5.63754701773324 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/250*10)=-1.47393118833241 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: FUS [Title/Abstract] AND CREB3L2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CREB3L2(137686349)-FUS(31199645), # samples:2 FUS(31199514)-CREB3L2(137565145), # samples:1 FUS(31199478)-CREB3L2(137593090), # samples:1 FUS(31196384)-CREB3L2(137593099), # samples:1 FUS(31196358)-CREB3L2(137664456), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | CREB3L2-FUS seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. CREB3L2-FUS seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. CREB3L2-FUS seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. CREB3L2-FUS seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. CREB3L2-FUS seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. CREB3L2-FUS seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. FUS-CREB3L2 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. FUS-CREB3L2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. FUS-CREB3L2 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. FUS-CREB3L2 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. FUS-CREB3L2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. FUS-CREB3L2 seems lost the major protein functional domain in Tgene partner, which is a transcription factor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FUS | GO:0006355 | regulation of transcription, DNA-templated | 26124092 |
Hgene | FUS | GO:0006357 | regulation of transcription by RNA polymerase II | 25453086 |
Hgene | FUS | GO:0008380 | RNA splicing | 26124092 |
Hgene | FUS | GO:0043484 | regulation of RNA splicing | 25453086|27731383 |
Hgene | FUS | GO:0048255 | mRNA stabilization | 27378374 |
Hgene | FUS | GO:0051260 | protein homooligomerization | 25453086 |
Hgene | FUS | GO:1905168 | positive regulation of double-strand break repair via homologous recombination | 10567410 |
Tgene | CREB3L2 | GO:0045893 | positive regulation of transcription, DNA-templated | 17178827 |
Fusion gene breakpoints across FUS (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CREB3L2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | fibromyxoid sarcoma | AJ549093 | FUS | chr16 | 31199514 | CREB3L2 | chr7 | 137565145 | ||
ChimerKB3 | . | . | FUS | chr16 | 31195705 | + | CREB3L2 | chr7 | 137590594 | - |
ChimerKB3 | . | . | FUS | chr16 | 31195705 | + | CREB3L2 | chr7 | 137593182 | - |
ChimerKB3 | . | . | FUS | chr16 | 31196384 | + | CREB3L2 | chr7 | 137565145 | - |
ChimerKB3 | . | . | FUS | chr16 | 31196500 | + | CREB3L2 | chr | 137593182 | - |
ChimerKB3 | . | . | FUS | chr16 | 31196500 | + | CREB3L2 | chr7 | 137593182 | - |
ChimerKB3 | . | . | FUS | chr16 | 31199514 | + | CREB3L2 | chr7 | 137565145 | - |
ChimerKB4 | . | . | FUS | chr16 | 31195705 | + | CREB3L2 | chr7 | 137593182 | - |
ChimerKB4 | . | . | FUS | chr16 | 31196500 | + | CREB3L2 | chr7 | 137593182 | - |
ChiTaRS5.0 | N/A | AJ549093 | FUS | chr16 | 31199478 | - | CREB3L2 | chr7 | 137593090 | - |
ChiTaRS5.0 | N/A | AJ549094 | FUS | chr16 | 31196384 | + | CREB3L2 | chr7 | 137593099 | - |
ChiTaRS5.0 | N/A | AJ549097 | FUS | chr16 | 31196358 | + | CREB3L2 | chr7 | 137664456 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000254108 | FUS | chr16 | 31195705 | + | ENST00000330387 | CREB3L2 | chr7 | 137593182 | - | 6929 | 452 | 73 | 1431 | 452 |
ENST00000254108 | FUS | chr16 | 31195705 | + | ENST00000456390 | CREB3L2 | chr7 | 137593182 | - | 1867 | 452 | 73 | 1251 | 392 |
ENST00000380244 | FUS | chr16 | 31195705 | + | ENST00000330387 | CREB3L2 | chr7 | 137593182 | - | 6897 | 420 | 44 | 1399 | 451 |
ENST00000380244 | FUS | chr16 | 31195705 | + | ENST00000456390 | CREB3L2 | chr7 | 137593182 | - | 1835 | 420 | 44 | 1219 | 391 |
ENST00000568685 | FUS | chr16 | 31195705 | + | ENST00000330387 | CREB3L2 | chr7 | 137593182 | - | 6888 | 411 | 32 | 1390 | 452 |
ENST00000568685 | FUS | chr16 | 31195705 | + | ENST00000456390 | CREB3L2 | chr7 | 137593182 | - | 1826 | 411 | 32 | 1210 | 392 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >31795_31795_1_FUS-CREB3L2_FUS_chr16_31195705_ENST00000254108_CREB3L2_chr7_137593182_ENST00000330387_length(amino acids)=452AA_BP=126 MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTVVIASPRTLQAMARAAILLMARARTQAMELSQLPRDMARLA AMAVARAPNRLTGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSLSPNPRLHPFSLPQTHSPSRAAPRAPSALSS SPLLTAPHKLQGSGPLVLTEEEKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEYMDSLEKKVESCSTENLELRK KVEVLENTNRTLLQQLQKLQTLVMGKVSRTCKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPYTASVVRSRN LLIYEEHSPPEESSSPGSAGELGGWDRGSSLLRVSGLESRPDVDLPHFIISNETSLEKSVLLELQQHLVSAKLEGNETLKVVELDRRVNT -------------------------------------------------------------- >31795_31795_2_FUS-CREB3L2_FUS_chr16_31195705_ENST00000254108_CREB3L2_chr7_137593182_ENST00000456390_length(amino acids)=392AA_BP=126 MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTVVIASPRTLQAMARAAILLMARARTQAMELSQLPRDMARLA AMAVARAPNRLTGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSLSPNPRLHPFSLPQTHSPSRAAPRAPSALSS SPLLTAPHKLQGSGPLVLTEEEKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEYMDSLEKKVESCSTENLELRK KVEVLENTNRTLLQQLQKLQTLVMGKVSRTCKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPYTASVGKTAC -------------------------------------------------------------- >31795_31795_3_FUS-CREB3L2_FUS_chr16_31195705_ENST00000380244_CREB3L2_chr7_137593182_ENST00000330387_length(amino acids)=451AA_BP=125 MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTVVIASPRTLQAMARAAILLMARARTAMELSQLPRDMARLAA MAVARAPNRLTGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSLSPNPRLHPFSLPQTHSPSRAAPRAPSALSSS PLLTAPHKLQGSGPLVLTEEEKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEYMDSLEKKVESCSTENLELRKK VEVLENTNRTLLQQLQKLQTLVMGKVSRTCKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPYTASVVRSRNL LIYEEHSPPEESSSPGSAGELGGWDRGSSLLRVSGLESRPDVDLPHFIISNETSLEKSVLLELQQHLVSAKLEGNETLKVVELDRRVNTT -------------------------------------------------------------- >31795_31795_4_FUS-CREB3L2_FUS_chr16_31195705_ENST00000380244_CREB3L2_chr7_137593182_ENST00000456390_length(amino acids)=391AA_BP=125 MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTVVIASPRTLQAMARAAILLMARARTAMELSQLPRDMARLAA MAVARAPNRLTGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSLSPNPRLHPFSLPQTHSPSRAAPRAPSALSSS PLLTAPHKLQGSGPLVLTEEEKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEYMDSLEKKVESCSTENLELRKK VEVLENTNRTLLQQLQKLQTLVMGKVSRTCKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPYTASVGKTACG -------------------------------------------------------------- >31795_31795_5_FUS-CREB3L2_FUS_chr16_31195705_ENST00000568685_CREB3L2_chr7_137593182_ENST00000330387_length(amino acids)=452AA_BP=126 MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTVVIASPRTLQAMARAAILLMARARTQAMELSQLPRDMARLA AMAVARAPNRLTGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSLSPNPRLHPFSLPQTHSPSRAAPRAPSALSS SPLLTAPHKLQGSGPLVLTEEEKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEYMDSLEKKVESCSTENLELRK KVEVLENTNRTLLQQLQKLQTLVMGKVSRTCKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPYTASVVRSRN LLIYEEHSPPEESSSPGSAGELGGWDRGSSLLRVSGLESRPDVDLPHFIISNETSLEKSVLLELQQHLVSAKLEGNETLKVVELDRRVNT -------------------------------------------------------------- >31795_31795_6_FUS-CREB3L2_FUS_chr16_31195705_ENST00000568685_CREB3L2_chr7_137593182_ENST00000456390_length(amino acids)=392AA_BP=126 MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTVVIASPRTLQAMARAAILLMARARTQAMELSQLPRDMARLA AMAVARAPNRLTGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSLSPNPRLHPFSLPQTHSPSRAAPRAPSALSS SPLLTAPHKLQGSGPLVLTEEEKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEYMDSLEKKVESCSTENLELRK KVEVLENTNRTLLQQLQKLQTLVMGKVSRTCKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPYTASVGKTAC -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:137686349/chr7:31199645) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
FUS | CREB3L2 |
FUNCTION: DNA/RNA-binding protein that plays a role in various cellular processes such as transcription regulation, RNA splicing, RNA transport, DNA repair and damage response (PubMed:27731383). Binds to nascent pre-mRNAs and acts as a molecular mediator between RNA polymerase II and U1 small nuclear ribonucleoprotein thereby coupling transcription and splicing (PubMed:26124092). Binds also its own pre-mRNA and autoregulates its expression; this autoregulation mechanism is mediated by non-sense-mediated decay (PubMed:24204307). Plays a role in DNA repair mechanisms by promoting D-loop formation and homologous recombination during DNA double-strand break repair (PubMed:10567410). In neuronal cells, plays crucial roles in dendritic spine formation and stability, RNA transport, mRNA stability and synaptic homeostasis (By similarity). {ECO:0000250|UniProtKB:P56959, ECO:0000269|PubMed:10567410, ECO:0000269|PubMed:24204307, ECO:0000269|PubMed:26124092, ECO:0000269|PubMed:27731383}. | FUNCTION: Transcription factor involved in unfolded protein response (UPR). In the absence of endoplasmic reticulum (ER) stress, inserted into ER membranes, with N-terminal DNA-binding and transcription activation domains oriented toward the cytosolic face of the membrane. In response to ER stress, transported to the Golgi, where it is cleaved in a site-specific manner by resident proteases S1P/MBTPS1 and S2P/MBTPS2. The released N-terminal cytosolic domain is translocated to the nucleus to effect transcription of specific target genes. Plays a critical role in chondrogenesis by activating the transcription of SEC23A, which promotes the transport and secretion of cartilage matrix proteins, and possibly that of ER biogenesis-related genes (By similarity). In a neuroblastoma cell line, protects cells from ER stress-induced death (PubMed:17178827). In vitro activates transcription of target genes via direct binding to the CRE site (PubMed:17178827). {ECO:0000250|UniProtKB:Q8BH52, ECO:0000269|PubMed:17178827}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Protein Structures |
PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file (145) >>>145.pdbFusion protein BP residue: 125 CIF file (145) >>>145.cif | FUS | chr16 | 31195705 | + | CREB3L2 | chr7 | 137593182 | - | MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTV VIASPRTLQAMARAAILLMARARTAMELSQLPRDMARLAAMAVARAPNRL TGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSLS PNPRLHPFSLPQTHSPSRAAPRAPSALSSSPLLTAPHKLQGSGPLVLTEE EKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEYM DSLEKKVESCSTENLELRKKVEVLENTNRTLLQQLQKLQTLVMGKVSRTC KLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPY | 391 |
3D view using mol* of 145 (AA BP:125) | ||||||||||
PDB file (147) | FUS | chr16 | 31195705 | + | CREB3L2 | chr7 | 137593182 | - | MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTV VIASPRTLQAMARAAILLMARARTQAMELSQLPRDMARLAAMAVARAPNR LTGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSL SPNPRLHPFSLPQTHSPSRAAPRAPSALSSSPLLTAPHKLQGSGPLVLTE EEKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEY MDSLEKKVESCSTENLELRKKVEVLENTNRTLLQQLQKLQTLVMGKVSRT CKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEP | 392 |
PDB file (220) >>>220.pdbFusion protein BP residue: 125 CIF file (220) >>>220.cif | FUS | chr16 | 31195705 | + | CREB3L2 | chr7 | 137593182 | - | MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTV VIASPRTLQAMARAAILLMARARTAMELSQLPRDMARLAAMAVARAPNRL TGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSLS PNPRLHPFSLPQTHSPSRAAPRAPSALSSSPLLTAPHKLQGSGPLVLTEE EKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEYM DSLEKKVESCSTENLELRKKVEVLENTNRTLLQQLQKLQTLVMGKVSRTC KLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPY TASVVRSRNLLIYEEHSPPEESSSPGSAGELGGWDRGSSLLRVSGLESRP DVDLPHFIISNETSLEKSVLLELQQHLVSAKLEGNETLKVVELDRRVNTT | 451 |
3D view using mol* of 220 (AA BP:125) | ||||||||||
PDB file (221) >>>221.pdbFusion protein BP residue: 126 CIF file (221) >>>221.cif | FUS | chr16 | 31195705 | + | CREB3L2 | chr7 | 137593182 | - | MLACLCARARTWPQTIIPNKQPKAMGPTPPSPGRAIPSRAVSPTDSRVTV VIASPRTLQAMARAAILLMARARTQAMELSQLPRDMARLAAMAVARAPNR LTGSSPPTLAMASSQLPAAPREGGGGAPVDHLHLPPTPPSSHGSDSEGSL SPNPRLHPFSLPQTHSPSRAAPRAPSALSSSPLLTAPHKLQGSGPLVLTE EEKRTLIAEGYPIPTKLPLSKSEEKALKKIRRKIKNKISAQESRRKKKEY MDSLEKKVESCSTENLELRKKVEVLENTNRTLLQQLQKLQTLVMGKVSRT CKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEP YTASVVRSRNLLIYEEHSPPEESSSPGSAGELGGWDRGSSLLRVSGLESR PDVDLPHFIISNETSLEKSVLLELQQHLVSAKLEGNETLKVVELDRRVNT | 452 |
3D view using mol* of 221 (AA BP:126) | ||||||||||
Top |
pLDDT score distribution |
pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
FUS_pLDDT.png |
pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
Top |
Ramachandran Plot of Fusion Protein Structure |
Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
FUS_CREB3L2_145.png |
FUS_CREB3L2_147.png |
FUS_CREB3L2_220.png |
FUS_CREB3L2_221.png |
Top |
Potential Active Site Information |
The potential binding sites of these fusion proteins were identified using SiteMap, a module of the Schrodinger suite. |
Fusion AA seq ID in FusionPDB | Site score | Size | D score | Volume | Exposure | Enclosure | Contact | Phobic | Philic | Balance | Don/Acc | Residues |
145 | 1.042 | 144 | 1.104 | 362.208 | 0.575 | 0.673 | 0.884 | 1.198 | 0.735 | 1.63 | 0.869 | Chain A: 193,194,195,196,197,202,204,205,208,210,2 12,213,214,215,216,218,222,223,224,225,226,227,228 ,229,230,232,233,236 |
147 | 1.089 | 97 | 1.197 | 240.1 | 0.531 | 0.656 | 0.925 | 2.021 | 0.374 | 5.4 | 1.53 | Chain A: 52,53,55,58,59,61,62,63,65,66,67,69,318,3 19,322,323,326,327,330 |
220 | 0.945 | 69 | 0.993 | 181.104 | 0.599 | 0.67 | 0.899 | 1.875 | 0.58 | 3.231 | 1.643 | Chain A: 193,194,195,196,197,202,205,210,211,212,2 13,215,216,218,221,222,225,226,229 |
221 | 0.912 | 69 | 0.936 | 197.225 | 0.577 | 0.67 | 0.888 | 0.85 | 0.759 | 1.121 | 1.093 | Chain A: 194,195,196,197,198,203,206,213,214,215,2 17,219,223,226,227,230,231 |
Top |
Potentially Interacting Small Molecules through Virtual Screening |
The FDA-approved small molecule library molecules were subjected to virtual screening using the Glide. |
Fusion AA seq ID in FusionPDB | ZINC ID | DrugBank ID | Drug name | Docking score | Glide gscore |
Top |
Drug information from DrugBank of the top 20 interacting small molecules. |
ZINC ID | DrugBank ID | Drug name | Drug type | SMILES | Drug group |
Top |
Biochemical Features of Small Molecules |
ADME (Absorption, Distribution, Metabolism, and Excretion) of drugs using QikProp(v3.9) |
ZINC ID | mol_MW | dipole | SASA | FOSA | FISA | PISA | WPSA | volume | donorHB | accptHB | IP | Human Oral Absorption | Percent Human Oral Absorption | Rule Of Five | Rule Of Three |
Top |
Drug Toxicity Information |
Toxicity information of individual drugs using eToxPred |
ZINC ID | Smile | Surface Accessibility | Toxicity |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
FUS | EIF6, USF2, PRMT1, PTBP2, SRRM1, SPI1, YBX1, ILF3, SF1, SRSF10, THRA, RXRA, RELA, OTUB1, ZMYM2, SARNP, TARDBP, Mapk13, DGCR8, Pds5a, Shoc2, Ccdc15, PCM1, SF3A2, SIRT7, SQSTM1, TDRD3, CUL3, CUL4A, CUL4B, CUL5, CUL2, CDK2, CUL1, COPS5, COPS6, DCUN1D1, CAND1, NEDD8, ARHGEF28, PA2G4, UBE2I, ATXN1L, GRB2, PIK3R2, HNRNPA3, NONO, EEF1A1, DYNC1H1, GSE1, MBD3, MRPS18B, SAP30BP, RPLP1, ESR1, FN1, VCAM1, TP63, IL7R, UBL4A, ITGA4, CTNNB1, ECM32, NAM8, SBP1, SKO1, VHR1, UPF1, LMNA, EWSR1, RBMX, PSMB7, ESRRA, MDH1, TAF15, SRSF9, SAFB2, TNIP1, KHDRBS3, NKD2, MAX, PARK2, SUV39H1, WBP4, HNRNPU, LARS, rev, RPA3, RPA2, RPA1, WWOX, HSPA5, VCP, SFPQ, YWHAZ, YWHAQ, PFN1, FASN, PGK1, CKB, ENO1, LDHB, PAICS, PHGDH, LDHA, GAPDH, PKM, ATXN2L, MTHFD1, ACACA, CA2, ALDOA, GPI, PYCRL, PFKL, PGM1, ABCA1, HPRT1, PM20D2, TKT, UBA1, PSMD12, CDH4, ANXA2P2, GNAS, PLCE1, TRPM4, SLC1A5, UBAP2, UBAP2L, LYZ, CKAP4, YPEL1, HIST4H4, H3F3A, H3F3B, HIST2H2BE, DDX42, HNRNPD, SYNCRIP, DHX40, SF3A1, SF3B3, SF3B4, SERBP1, FANCM, RAD54B, PCNA, PHB, TP73, RPL18, RPL9, RPS9, TBPL1, TRIP4, DNAJC10, SAE1, DLD, GOT2, ATP5A1, GSTP1, HARS2, SLC25A3, KPNA2, RAB7A, SPATA6, UACA, STATH, ANXA5, MAP3K3, UBC, TUBB, CFL1, TUBA1A, ACTB, HNRNPF, HNRNPH1, DHX15, CPSF6, SF3A3, HNRNPK, PSPC1, HNRNPL, RPS5, RPS8, RPL12, RPN2, EEF2, EEF1G, HSP90AA1, CCT5, CCT6A, HSP90AB1, CCT2, CCT4, HSP90B1, CCT3, CCT7, CCT8, HSPA8, PPIL4, TCP1, PDIA3, PPIA, SSBP1, GLUD1, ATP5B, HSPA9, ERAL1, TUFM, HSPD1, PYCR1, MDH2, ABCF2, KPNB1, PRDX1, ERP44, F7, ALB, ARMC6, ADCK5, CCDC88A, GPR101, ITK, DGKA, SLC22A11, HERC6, TUBA1B, MTSS1L, CEP112, COL18A1, SEC13, NAP1L1, SNRPD2, NCAPG2, RBBP4, FLJ22447, LSM12, NUDT21, DDX1, C14orf166, DDX5, HIVEP3, NCOA6, RAVER1, TCEB1, TXNL4B, TTI2, GEN1, RPL14, RPS14, NPM1, RPL11, RPL4, EIF4A1, PCBP2, ST13, NSDHL, MTAP, MAT2A, AHCY, OAT, BCS1L, SLC25A5, TIMM50, MYH10, GOLIM4, CSE1L, RAN, KLHL40, KLHL5, IGKV1-5, C6, GIMAP8, CDC5L, CEP78, DBF4B, AMOT, FAM71F1, MFGE8, FAM98A, C11orf70, RTCB, UFL1, LRRIQ4, NUPR1, CUL7, OBSL1, EZH2, SUZ12, BMI1, ABL1, CHEK1, SIK2, SRPK1, DBR1, LUZP4, UPF2, UPF3A, FAM58A, YEATS4, RPS6KB2, HNRNPA1, HSP104, FBXW11, ACAT1, ARMC1, C2orf49, DDX17, DNAJC7, EIF4H, AURKA, PTBP1, TOMM34, TXLNA, UFD1L, HNRNPDL, MEF2D, NAA50, NPLOC4, PFKP, PICALM, TARS, NTRK1, SCARNA22, TCF7L2, KIF22, EMC2, MATR3, MCM2, SNW1, RC3H1, EGFR, TRAF6, CRBN, KCTD6, RPS27, PSRC1, SMCO3, CYLD, TRIM25, BRCA1, HDAC6, WDR77, PCBP1, PPIE, YAP1, EFTUD2, AAR2, PIH1D1, NKX2-1, CHD3, CHD4, TNF, HEXIM1, MEPCE, LARP7, RUNX1, PPT1, CTDSPL2, AGR2, RECQL4, CDK9, ARID1A, SMARCA4, SMARCD1, DDIT3, SMARCC2, SMARCC1, SS18, SMARCB1, FLI1, TP53BP1, MDC1, METTL3, METTL14, KIAA1429, RC3H2, ATG16L1, LINC00470, AKT1, ACTC1, RBX1, MYC, MAPT, HIV2gp4, HIV2gp3, NR2C2, UBQLN2, HDAC2, ZFYVE21, XRCC6, DYNLT1, HIST1H4A, SNRNP70, SNRPA, SRSF1, SNRPB, SNRPC, SNRPD1, SNRPD3, RNU1-1, FUS, TRIM28, HNRNPA2B1, HNRNPR, PPP1R10, ILF2, DHX9, PABPC1, DDX3X, SRSF7, HNRNPM, HNRNPUL1, PABPC4, SF3B1, LARP1, PBRM1, THRAP3, MOV10, FAM120A, SKIV2L2, TOX, POLR2A, ELAVL1, SF3B2, STRBP, WDR82, HNRNPCL1, CCNT1, RBM14, U2SURP, DDX20, HIST1H1C, NUMA1, CCBL2, ZFR, ACIN1, CDC73, DDX23, SLTM, SRRT, IGF2BP3, ZC3H18, PRRC2A, HNRNPUL2, THOC1, AKAP8, BCLAF1, SRSF3, CHERP, INTS12, PAF1, PNN, PPFIA1, RBM10, SNRNP200, TOE1, TRA2B, HNRNPC, HNRNPA0, PPP1CC, CCAR1, DDX21, HNRNPAB, INTS6, POLR2B, PRPF6, RALY, RBM25, RBM7, SAFB, THOC5, XRN2, EBNA1BP2, HSPA1A, RBM39, STRAP, TRA2A, YBX3, ZCCHC8, GPATCH8, SMN1, SRSF5, CTR9, EIF4A3, GNL3, HNRNPH3, HP1BP3, NCBP1, PRPF19, RBM17, RRP9, THOC2, ZC3HAV1, EXOSC10, GEMIN6, XAB2, HSPB1, PABPN1, CAPRIN1, CCAR2, GEMIN4, INTS4, KHDRBS1, PLRG1, PRMT5, SRSF6, ZNF326, ADAR, ARID2, GEMIN5, PHF10, PURB, SMU1, TOX4, AQR, ITFG1, ARAF, BIRC3, NFX1, VPS15, VPS34, VPS38, VPS8, PEP3, VPS21, CDC48, UBX3, BRE5, UBP3, SOX2, EP300, CMTR1, ARIH2, PLEKHA4, PINK1, PRMT8, FANCD2, MIRLET7A1, MIRLET7A2, MIRLET7A3, MIRLET7B, MIRLET7C, MIRLET7D, MIRLET7E, MIRLET7F1, MIRLET7F2, MIRLET7G, MIRLET7I, MIR98, MIR1-1, MIR1-2, MIR7-1, MIR7-2, MIR7-3, MIR9-1, MIR9-2, MIR9-3, MIR10B, MIR15A, MIR15B, MIR16-1, MIR16-2, MIR17, MIR18A, MIR18B, MIR19A, MIR19B1, MIR19B2, MIR20A, MIR20B, MIR21, MIR25, MIR29A, MIR29B1, MIR29B2, MIR29C, MIR31, MIR34A, MIR34B, MIR34C, MIR92A1, MIR92A2, MIR93, MIR106A, MIR106B, MIR107, MIR122, MIR128-1, MIR128-2, MIR138-1, MIR138-2, MIR140, MIR141, MIR143, MIR145, MIR155, MIR199A1, MIR199A2, MIR200A, MIR200B, MIR200C, MIR205, MIR206, MIR214, MIR221, MIR222, MIR363, MIR429, MIR451A, ADAMTS9-AS2, MDM2, OPTN, PRKD1, HVCN1, CELF1, FUBP3, DUX4, DUX4L9, CIT, CHMP4B, ECT2, KIF14, KIF20A, KIF23, PRC1, MKI67, BRD4, NINL, RBM45, UCHL1, Apc2, FBP1, LGALS9, WDR76, EIF3F, CREBBP, vpr, RNF4, OGT, CD274, SPOP, DDRGK1, TP53, DDX39B, HIST1H2BG, USP15, FZR1, WDR5, NUDCD2, CPSF1, NUP43, BTF3, BSG, S, RCHY1, NBR1, BACH2, PDE4B, SIRT6, |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
FUS | |
CREB3L2 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to FUS-CREB3L2 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to FUS-CREB3L2 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
FUS | CREB3L2 | Low Grade Fibromyxoid Sarcoma | MyCancerGenome | |
FUS | CREB3L2 | Lung Adenocarcinoma | MyCancerGenome | |
FUS | CREB3L2 | Breast Invasive Ductal Carcinoma | MyCancerGenome | |
FUS | CREB3L2 | Glioblastoma | MyCancerGenome | |
FUS | CREB3L2 | Pancreatic Adenocarcinoma | MyCancerGenome |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FUS | C1842675 | AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder) | 5 | UNIPROT |
Hgene | FUS | C3468114 | Juvenile amyotrophic lateral sclerosis | 5 | ORPHANET |
Hgene | FUS | C0002736 | Amyotrophic Lateral Sclerosis | 2 | CTD_human;ORPHANET |
Hgene | FUS | C0206634 | Liposarcoma, Myxoid | 2 | CTD_human;ORPHANET |
Hgene | FUS | C0393554 | Amyotrophic Lateral Sclerosis With Dementia | 1 | CTD_human |
Hgene | FUS | C0497327 | Dementia | 1 | GENOMICS_ENGLAND |
Hgene | FUS | C0543859 | Amyotrophic Lateral Sclerosis, Guam Form | 1 | CTD_human |
Hgene | FUS | C3539195 | TREMOR, HEREDITARY ESSENTIAL, 4 | 1 | CTD_human;UNIPROT |
Hgene | FUS | C3888102 | Frontotemporal Dementia With Motor Neuron Disease | 1 | ORPHANET |